Manlu Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Manlu Xiao has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Jia Wen
Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2 shared publicationsZhilian Li
Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2 shared publications- Cailin Su
Department of Endocrinology and Metabolism, Nanfang Hospital Southern Medical University Guangzhou China
1 shared publication Danna Chen
Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
1 shared publicationDantong Li
Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510080, China
1 shared publicationDinglin Liu
Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Single-cell Stereo-seq reveals regulatory mechanisms driving regeneration of injured proximal tubules during AKI
Acute kidney injury (AKI) is a clinical syndrome characterized by a rapid decline in renal function. Proximal tubule (PT) cells play a central role in AKI. However, the specific populations and states of PT that facilitate repair remain poorly understood. Here, we combine spatial enhanced resolution omics sequencing with single-nucleus RNA sequencing to profile kidney transcriptomes during AKI. We identify an ischemia-reperfusion injury-induced PT subtype, termed proliferative PT, that likely initiates renal regeneration and exhibits a gene expression enriched in mitosis and metabolic processes. Acsm2 is expressed in proliferative PT and is associated with cell cycle progression. Functional studies reveal the protective role of Acsm2 via deficiency and overexpressing mice. Finally, we identify a subcluster of Fibroblast (FIB_C2) that participates in PT repair through cell-cell communication with proliferative PT. Our study provides an integrated high-resolution spatiotemporal atlas of AKI and reveals the important role of Acsm2 in kidney regeneration.
- 6 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessSingle-cell Stereo-seq reveals regulatory mechanisms driving regeneration of injured proximal tubules during AKI
Acute kidney injury (AKI) is a clinical syndrome characterized by a rapid decline in renal function. Proximal tubule (PT) cells play a central role in AKI. However, the specific populations and states of PT that facilitate repair remain poorly understood. Here, we combine spatial enhanced resolution omics sequencing with single-nucleus RNA sequencing to profile kidney transcriptomes during AKI. We identify an ischemia-reperfusion injury-induced PT subtype, termed proliferative PT, that likely initiates renal regeneration and exhibits a gene expression enriched in mitosis and metabolic processes. Acsm2 is expressed in proliferative PT and is associated with cell cycle progression. Functional studies reveal the protective role of Acsm2 via deficiency and overexpressing mice. Finally, we identify a subcluster of Fibroblast (FIB_C2) that participates in PT repair through cell-cell communication with proliferative PT. Our study provides an integrated high-resolution spatiotemporal atlas of AKI and reveals the important role of Acsm2 in kidney regeneration.
- 30 January 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 806, 153348
Proteomic insights into the dynamic inflammatory and metabolic networks of renal ischemia–reperfusion injury
- 30 January 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 806, 153348
Proteomic insights into the dynamic inflammatory and metabolic networks of renal ischemia–reperfusion injury
- Open Access
- 9 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (5) , e70455
Polo‐like kinase2 regulates renal tubulointerstitial fibrosis via notch signaling pathway in diabetic kidney disease
Renal tubulointerstitial fibrosis is considered as an important pathological feature of diabetic kidney disease (DKD). However, the underlying mechanism remains unclear. Polo‐like kinase2 (PLK2) is a known player in the regulation of organ fibrosis. Herein, we investigated the expression and function of PLK2 in renal tubular epithelial cells in DKD. Data from the GSE30529 datasets were subjected to analyze the differentially expressed genes (DEGs) in non‐diabetic and diabetic renal tubule samples. Molecular docking analysis and Co‐IP assay were performed to investigate the interaction between PLK2 and NOTCH1. Immunohistochemistry, immunofluorescent staining, qRT‐PCR, and western blot were performed. Our research revealed an increased expression of PLK2 in both DKD mouse kidney tissues and HK‐2 cells stimulated by high glucose (HG). Silencing PLK2 remarkably reduced the expression of the renal fibrosis‐related markers fibronectin (FN), connective tissue growth factor (CTGF) and alpha smooth muscle actin(αSMA). Furthermore, we verified the interaction between PLK2 and NOTCH1. Silencing PLK2 significantly inhibited the activation of the Notch signaling pathway, and concurrently overexpressing HES1 rescued the downregulation of FN, CTGF, and αSMA induced by transfecting si‐PLK2. Finally, we found that treatment with DAPT suppressed the activation of the Notch signaling pathway and reversed the progression of renal fibrosis caused by HG. This study demonstrates that PLK2 mediates renal tubulointerstitial fibrosis in DKD by activating the Notch signaling pathway, suggesting that PLK2 may be a potential therapeutic target for DKD.
- 9 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (5) , e70455
Open AccessPolo‐like kinase2 regulates renal tubulointerstitial fibrosis via notch signaling pathway in diabetic kidney disease
Renal tubulointerstitial fibrosis is considered as an important pathological feature of diabetic kidney disease (DKD). However, the underlying mechanism remains unclear. Polo‐like kinase2 (PLK2) is a known player in the regulation of organ fibrosis. Herein, we investigated the expression and function of PLK2 in renal tubular epithelial cells in DKD. Data from the GSE30529 datasets were subjected to analyze the differentially expressed genes (DEGs) in non‐diabetic and diabetic renal tubule samples. Molecular docking analysis and Co‐IP assay were performed to investigate the interaction between PLK2 and NOTCH1. Immunohistochemistry, immunofluorescent staining, qRT‐PCR, and western blot were performed. Our research revealed an increased expression of PLK2 in both DKD mouse kidney tissues and HK‐2 cells stimulated by high glucose (HG). Silencing PLK2 remarkably reduced the expression of the renal fibrosis‐related markers fibronectin (FN), connective tissue growth factor (CTGF) and alpha smooth muscle actin(αSMA). Furthermore, we verified the interaction between PLK2 and NOTCH1. Silencing PLK2 significantly inhibited the activation of the Notch signaling pathway, and concurrently overexpressing HES1 rescued the downregulation of FN, CTGF, and αSMA induced by transfecting si‐PLK2. Finally, we found that treatment with DAPT suppressed the activation of the Notch signaling pathway and reversed the progression of renal fibrosis caused by HG. This study demonstrates that PLK2 mediates renal tubulointerstitial fibrosis in DKD by activating the Notch signaling pathway, suggesting that PLK2 may be a potential therapeutic target for DKD.